Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
12/2008
12/24/2008WO2008157537A2 Compositions and methods of use for treating or preventing lipid related disorders
12/24/2008WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors
12/24/2008WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
12/24/2008EP2004642A1 Bifunctional polyazamacrocyclic chelating agents
12/24/2008EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
12/23/2008US7468435 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
12/23/2008US7468360 Therapeutic amides and related compounds
12/23/2008CA2386627C Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
12/23/2008CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity
12/23/2008CA2288148C A process for the preparation of 1,4,7,10-tetraazacyclododecane
12/23/2008CA2238427C Production method of aminobenzene compound
12/18/2008US20080312430 Method of Preparing or Synthesizing Polyazamacrocycle Derivatives
12/18/2008US20080312286 Indanone Potentiators of Metabotropic Glutamate Receptors
12/17/2008CN101323610A Novel preparation of trityl group candesartan cilexetil intermediate
12/16/2008US7465804 3-[p-(substituted benzyloxy)- or p-(substituted -5-thiazolylmethoxy)phenyl]propionic acid derivatives in which the propionic acid is 3-substituted with a carbamoyl-, imidazolyl-, triazolyl-, tetrazolyl-, or oxazolyl group; activating G-protein coupled receptor 40; treatment of type II diabetes
12/11/2008WO2008148599A2 Process for obtaining a valsartan salt useful for obtaining valsartan
12/11/2008WO2007092364A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306128 new forms of 2-butyl-1-[2'-(1H-tetrazol-5-yl)bifenyl-4-yl-methyl]spiro[2-imidazoline-4.1'-cyclopentane]-5-one; antagonist of angiotensin-II receptors
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306067 Modulators of Chemokine Receptor Activity
12/10/2008EP1999118A2 Metal complexes of tetraazamacrocycle derivatives
12/10/2008CN101321750A Multimeric magnetic resonance contrast agents
12/09/2008US7462617 Substituted acylpiperazine derivatives
12/04/2008US20080300289 (R,S)-5-[1-(4'-tert-Butyl-2,6-dimethyl-biphenyl-4-ylsulfanyl)-2-methyl-propyl]-thiophene-2-carboxylic acid (2H-tetrazol-5-ylmethyl)-amide, used for the treatment of metabolic disorders, such as diabetes, non-insulin dependent diabetes and hyperglycemia
12/04/2008US20080300220 Linkable Lewis X Analogs
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/03/2008EP1996564A1 Dibenzyl amine compounds and derivatives
12/03/2008EP1426371B1 Tetrazoyl oxime derivatives and agrochemicals containing the same as the active ingredient
12/03/2008CN101314595A Aromatic hydrocarbons connected multi-polyamine large-ring derivants, preparation method and medical use thereof
12/02/2008US7459551 Method for preparing cyclic compounds
11/2008
11/27/2008WO2008143724A2 Explosive complexes
11/27/2008US20080293791 Valsartan salts
11/27/2008US20080293790 Substituted aryl oximes
11/27/2008US20080293775 Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease
11/27/2008US20080293747 Chemical Synthesis of a Highly Potent Epothilone
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/26/2008EP1995241A1 Inhibitors of ion channels
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008CN100436418C N-Benzyl-3-indenylacetamides derivatives for treating neoplasia
11/25/2008US7456206 Biaryl heterocyclic compounds and methods of making and using the same
11/25/2008CA2539338C Process for production of 1-aryl-5-(trifluoromethyl)-1h-tetrazoles
11/20/2008WO2008139987A1 G-protein-conjugated receptor agonist
11/20/2008WO2008138871A1 Process for the preparation of valsartan
11/20/2008WO2008097459A3 Dual-acting antihypertensive agents
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287441 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
11/19/2008CN101309910A Process for obtaining valine derivatives useful for obtaining a pharmaceutically active compound
11/19/2008CN101307035A Manufacturing method of gas generant for air cell
11/19/2008CN101307034A Manufacturing method of gas generant for air cell
11/18/2008US7452874 Thrombopoietin mimetics
11/18/2008CA2305802C Amide derivatives or salts thereof
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/13/2008WO2008135762A1 Process for preparing valsartan
11/13/2008WO2008135591A1 Novel benzamidine derivatives useful as potassium channel modulators
11/13/2008WO2008135448A1 Beta-keto-amide derivatives useful as ion channel modulators
11/13/2008WO2008135447A1 Acetamide derivatives as potassium channel modulators
11/13/2008US20080281097 Process for Preparing an Angiotensin II Receptor Antagonist
11/13/2008CA2686156A1 Process for preparing valsartan
11/12/2008EP1893597B1 Ampa receptor potentiators
11/12/2008CN101305006A Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
11/12/2008CN100432049C Cycloalkene derivatives, process for producing the same and use
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/06/2008WO2008133288A1 Tricyclic aryl compounds
11/06/2008WO2008131582A1 The method for making candixatan ester and intermediates thereof
11/06/2008WO2008087656B1 Process for the preparation of unsymmetrically substituted biphenyl compounds
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275096 Process for the preparation of valsartan
11/05/2008EP1988084A1 Metal complex and use thereof
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008EP1322626B1 Process for preparation of n-1 protected n ring nitrogen containing cyclic polyamines and products thereof
11/05/2008CN101300013A [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008US7446208 Polymerization of dihydroxy(2,2-dimethyl) bis tetrazole with hexamethylene di-isocyanate, in presence of dimethylaminopyridine catalyst; as energetic binders to increase the performance of pyrotechnics, gun propellants, rocket propellants, air-bag gas generator propellants, and explosives
10/2008
10/30/2008WO2008131134A1 Hydrazide compounds and uses thereof
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008US20080269333 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
10/30/2008US20080269228 Hydrazide-containing hepatitis c serine protease inhibitors
10/30/2008US20080267866 Cross-bridged tetraamine macrocycles complexed with transition metal ions, radioactive metal species, fluorescent tag; as CXCR4 co-receptor antagonist is a dosage form for treatment of HIV; radiopharmaceutical for imaging chemokine receptors; drug screening assays for chemokine receptor binding
10/29/2008EP1983993A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/29/2008CN101296911A Arylurea derivatives as modulators of chemokine receptor activity
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261959 Novel crystalline forms of (S)-N-(1-Carboxy-2-methyl-prop-1-y)-N-pentanoyl-N[2'-(1H-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439261 Process for the preparation of valsartan and intermediates thereof
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080251169 Ionic liquid, a method of synthesizing an ionic liquid, a precursor of an explosive composition including at least one ionic liquid, and a method of desensitizing an explosive composition
10/16/2008CA2681861A1 Ornithine derivative
10/15/2008EP1979333A1 Process for preparing iodinated azoles
10/15/2008EP1638948B1 Diphenylurea derivatives and their use as chloride channel blockers
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008CN101284808A Compounds and methods for the inhibition of the expression of VCAM-1
10/09/2008WO2008120992A1 Novel antibiotics
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 97